Inventor
HOLM RENE
DK10 patents
⚠️ This page may combine multiple inventors who share the name “HOLM RENE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LUNDBECK & CO AS H
4 patentsUS8969355B2Mar 3, 2015
1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment
LUNDBECK & CO AS H15 citations92
US9227946B2Jan 5, 2016
1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment
LUNDBECK & CO AS H9 citations91
US9125908B2Sep 8, 2015
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
LUNDBECK & CO AS H11 citations91
US9125909B2Sep 8, 2015
1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
LUNDBECK & CO AS H9 citations91
H LUNDBECK AS
4 patentsUS9861630B1Jan 9, 2018
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
H LUNDBECK AS5 citations80
US11458134B2Oct 4, 2022
1-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
H LUNDBECK AS0 citations58
US11279682B2Mar 22, 2022
Vortioxetine pyroglutamate
H LUNDBECK AS0 citations57
US10287261B2May 14, 2019
Vortioxetine pyroglutamate
H LUNDBECK AS0 citations46